Search All News
Pathology laboratory screened New York state’s first potential donor—a COVID-19 survivor for antibodies that can be used to treat or vaccine against COVID-19.
Source:CBS New York
Dr. Eldad Hod talks on CBS on harnessing COVID-19 survirors' antibodies to fight the coronavirus disease in others.
NIH is giving out funds to develop seven new testing technologies which could increase testing capacity around the U.S. Daniel Green, MD, was quoted in this article about the RADx program.
They gave scientific presentations covering COVID-19 and non-COVID-19 basic science topics as well as their most current research.
Source:CBS New YorkApril 21, 2020
"Between 14 and 28 days after resolution of symptoms, we and others have found up to 30 % of individuals are still positive by the nasal swab, and they have antibodies too,” said Dr. Spitalnik.
Source:FPCApril 15, 2020
FPC Briefing with Dr, Eldad A. Hod, MD, associate professor of pathology an cell biology, and Diana Berrent, COVID-19 survivor and founder of Survivor Corps.
Source:CBC NewsApril 13, 2020
Convalescent plasma has been given to a small number of patients in the U.S. hoping it might help them fight off the virus. But the research is at early stages.
Source:Shrink Speak with Dr. LiebermanApril 8, 2020
Dr. Eldad Hod talks on his efforts to implement serological testing to identify patients who have recovered from COVID-19 and who may qualify as convalescent plasma donors.
Source:ABC Eyewitness NewsApril 7, 2020
"This is bigger than us all, so we're trying to do what we can," said Dr. Eldad Hod, "I've been working on this 24/7 for the past three weeks."
Source:CUIMC NewsroomFebruary 24, 2020
A team led by Pathology researcher, Alex Chavez, MD, PhD, will use a new drug screening approach to rapidly screen a large number of compounds that block the protease of 2019-nCoV.